Literature DB >> 6737498

Pertussis in nonimmunized postsurgical biliary atresia.

M S Johnson.   

Abstract

A case of pertussis in a patient who had undergone hepatic portocholecystostomy for biliary atresia is described. It has been recommended that infants with postsurgical biliary atresia forgo immunizations because of the high incidence of "ascending cholangitis." The patient in this study, however, had two characteristics that decreased her susceptibility to ascending cholangitis. This report suggests that patients with postsurgical biliary atresia who undergo hepatic portocholecystostomy rather than hepatic portoenterostomy or do not achieve bile drainage should be immunized according to schedule.

Entities:  

Mesh:

Year:  1984        PMID: 6737498      PMCID: PMC2561671     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Biliary obstruction and host defense failure.

Authors:  J M Holman; L F Rikkers
Journal:  J Surg Res       Date:  1982-03       Impact factor: 2.192

Review 2.  Biliary atresia: new concepts of management.

Authors:  D M Hays; K Kimura
Journal:  Curr Probl Surg       Date:  1981-09       Impact factor: 1.909

3.  Postoperative ascending cholangitis following portoenterostomy for biliary atresia: measures for control.

Authors:  J R Lilly; D C Hitch
Journal:  World J Surg       Date:  1978-09       Impact factor: 3.352

4.  Hepatic portocholecystostomy for biliary atresia.

Authors:  J R Lilly
Journal:  J Pediatr Surg       Date:  1979-06       Impact factor: 2.545

5.  Hepatic porto-enterostomy or cholecystostomy in the treatment of extrahepatic biliary atresia. A study of 49 cases.

Authors:  M Odiévre; J Valayer; M Razemon-Pinta; E C Habib; D Alagille
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

6.  Biliary atresia and the Kasai operation: continuing care.

Authors:  R M Barkin; J R Lilly
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.